Oncology
Conference Coverage
New cell-free DNA assays hold promise for lung cancer screening
CHICAGO – Three blood-based assays for circulating cell-free DNA detected lung cancer of stage I-IIIA had sensitivities of 38%-51% and...
From the Journals
Smoking tied to localized prostate cancer recurrence, metastasis, death
In the first systematic review and meta-analysis to look at the link between smoking and outcomes after localized prostate cancer primary therapy...
Conference Coverage
TAILORx marks major advance for precision medicine in breast cancer
CHICAGO – Practice-changing data show that most women with HR-positive, HER2-negative, early-stage breast cancer who have an intermediate...
Conference Coverage
Statin effect in prostate cancer may be caused by reduced inflammation
SAN FRANCISCO – Statin use is associated with lower lethality in prostate cancer. A new genetic analysis points to reduced inflammation in the...
Conference Coverage
Prostate cancer risk before age 55 higher for black men
SAN FRANCISCO – Efforts at identifying prostate cancer at an earlier age should consider black men as a high risk group.
Latest News
ACS: Start colorectal cancer screening at age 45
The updated guideline is based on an increasing burden of colorectal cancer in younger individuals.
Conference Coverage
Equal treatment, equal or better prostate cancer outcomes for black men
CHICAGO - “The nihilism associated with prostate cancer in African-American men is not supported by this really interesting work.”
Video
A blood test to detect lung cancer inches toward the clinic
CHICAGO - Dr. Geoffrey R. Oxnard discusses interim results from the Circulating Cell-Free Genome Atlas project and ongoing work to bring the blood...
Video
Stronger abiraterone response in mCRPC seen in black men
CHICAGO – Lead study author Dr. Daniel George discusses issues surrounding access to the standard of care for advanced prostate cancer.
Daily News Podcast
ACS: Screen for colon cancer at 45
And testosterone therapy may impact kidney stone risk.
